{"SPADE_UN_22289": {"Sequence Information": {"Peptide Name": "CP24-IBP", "Sequence": "MTWEEWDKKIEEYTKKIEELIKKSDCAWHLGELVWCT", "Sequence Length": 37, "Biological Activity": ["Antiviral"], "Binding Target": "1. Virus entry", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "Q5DP94", "uniprotUrl": "http://www.uniprot.org/uniprot/Q5DP94", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "IgG Fc-binding Motif-Conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-Life: Potential Application in Combination With Broad Neutralizing Antibodies.", "Pubmed ID": "31805154", "Reference": "PLoS Pathog. 2019;15:e1008082", "Author": "Bi W, Xu W, Cheng L, Xue J, Wang Q, Yu F, Xia S, Li G, Qin C, Lu L, Su L, Jiang S", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31805154"}], "Mass": 4600.25, "PI": 4.91, "Net Charge": -2, "Hydrophobicity": -0.77, "Frequent Amino Acids": "EKW", "Absent Amino Acids": "FNOPQRU", "Basic Residues": 7, "Acidic Residues": 9, "Hydrophobic Residues": 11, "Polar Residues": 26, "Positive Residues": 7, "Negative Residues": 9, "SPADE ID": "SPADE_UN_22289", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_14284", "Similarity": 1.0, "Sequence": "MTWEEWDKKIEEYTKKIEELIKKS"}, {"SPADE_ID": "SPADE_UN_14285", "Similarity": 1.0, "Sequence": "MTWEEWDKKIEEYTKKIEELIKK"}, {"SPADE_ID": "SPADE_UN_14286", "Similarity": 1.0, "Sequence": "MTWEEWDKKIEEYTKKIEELIK"}], "Hemolytic Activity": "", "Target Organism": "HIV-1 IIIB(IC50 I=0.0413µM),HIV-1 BaL(IC50 I=0.011µM)"}}}